ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

ACRV Acrivon Therapeutics Inc

9.59
1.13 (13.36%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Acrivon Therapeutics Inc ACRV NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
1.13 13.36% 9.59 13:00:01
始値 安値 高値 終値 前日終値
8.51 8.31 10.29 9.59 8.46
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2505:01GLOBEAcrivon Therapeutics Reports Initial Positive Clinical Data..
2024/4/1709:01GLOBEAcrivon Therapeutics to Host Corporate R&D Event..
2024/4/1021:00GLOBEAcrivon Therapeutics Presents Data at AACR Annual Meeting..
2024/4/0920:00GLOBEAcrivon Therapeutics Announces $130 Million Private..
2024/3/2821:00GLOBEAcrivon Therapeutics Reports Fourth Quarter and Full Year..
2024/3/0706:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0706:29EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/3/0606:30GLOBEAcrivon Therapeutics to Present Data at AACR Annual Meeting..
2024/3/0422:15EDGAR2Form 8-K - Current report
2024/3/0422:00GLOBEAcrivon Therapeutics Appoints Santhosh Palani, Ph.D., CFA,..
2024/2/2722:00GLOBEAcrivon Therapeutics to Participate in a Panel Discussion at..
2024/2/1707:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1707:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1707:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1707:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1707:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1707:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1405:40EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0822:27EDGAR2Form 8-K - Current report
2024/2/0822:00GLOBEAcrivon Therapeutics Appoints Seasoned Industry Executive..
2024/2/0622:00GLOBEAcrivon Therapeutics to Present at the Oppenheimer 34th..
2024/1/2006:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1306:00GLOBEAcrivon Therapeutics Announces Inducement Grants Under..
2024/1/0821:28EDGAR2Form 8-K - Current report
2024/1/0422:00GLOBEAcrivon Therapeutics to Present at the 42nd Annual J.P...
2023/12/1814:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/12/0906:21EDGAR2Form 8-K - Current report
2023/12/0206:35EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/11/2822:58DJNAcrivon Therapeutics Gets FDA's Breakthrough Designation for..
2023/11/2822:00GLOBEAcrivon Therapeutics Announces FDA has Granted Breakthrough..
2023/11/2122:00GLOBEAcrivon Therapeutics Announces Inducement Grant Under Nasdaq..
2023/11/1709:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1709:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1709:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1709:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1709:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1709:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0923:12EDGAR2Form 8-K - Current report
2023/11/0922:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0922:01GLOBEAcrivon Therapeutics Reports Third Quarter 2023 Financial..
2023/10/2008:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/1621:00GLOBEAcrivon Therapeutics Presents Data Demonstrating..
2023/9/2908:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/2908:13EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/9/2905:05GLOBEAcrivon Therapeutics Announces Inducement Grants Under..
2023/9/2005:32GLOBEAcrivon Therapeutics to Highlight its ACR-368 OncoSignature..
2023/9/0606:23EDGAR2Form 8-K - Current report
2023/9/0605:05GLOBEAcrivon Therapeutics Announces ACR-2316, a Novel Dual WEE1..
2023/8/3021:00GLOBEAcrivon Therapeutics to Participate in Two Investor..
2023/8/2405:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..

最近閲覧した銘柄

Delayed Upgrade Clock